We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-14.27%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$123B
AUM Growth
-$24.7B
(-17%)
Cap. Flow
-$418M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
30.06%
Holding
304
New
10
Increased
88
Reduced
149
Closed
13
Avg Time Held
3.8
years
Top 10 Avg Time Held
4.3
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$485M |
| 2 |
Hess
HES
|
+$460M |
| 3 |
Wells Fargo
WFC
|
+$356M |
| 4 |
Albemarle
ALB
|
+$291M |
| 5 |
Linde
LIN
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$468M |
| 2 |
Dell
DELL
|
+$283M |
| 3 |
Adobe
ADBE
|
+$261M |
| 4 |
Praxair Inc
PX
|
+$231M |
| 5 |
NetApp
NTAP
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.09% |
| 2 | Healthcare | 25.96% |
| 3 | Industrials | 15.66% |
| 4 | Financials | 9.32% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Newell Brands
NWL
$2.46B
| $71.3M | 0.06% |
3,835,960
-24,100
| -0.6% | -$479K |
2014 Q1
19 quarters
|
|
152
Ulta Beauty
ULTA
$26B
| $68.9M | 0.06% |
281,400
-2,000
| -0.7% | -$553K |
2017 Q4
4 quarters
|
|
153
FormFactor
FORM
$8.85B
| $64.9M | 0.05% |
4,609,118
-56,900
| -1% | -$793K |
2013 Q2
22 quarters
|
|
154
RTX Corp
RTX
$252B
| $64.5M | 0.05% |
963,191
+29,812
| +3% | +$2.34M |
2013 Q4
20 quarters
|
|
155
DELISTED
Faro Technologies
FARO
| $64.5M | 0.05% |
1,587,078
-85,100
| -5% | -$4.13M |
2013 Q2
22 quarters
|
|
156
Teradyne
TER
$53.7B
| $63.8M | 0.05% |
2,032,622
+153,450
| +8% | +$5.21M |
2015 Q3
13 quarters
|
|
157
HubSpot
HUBS
$11.9B
| $60.3M | 0.05% |
479,250
-21,000
| -4% | -$2.75M |
2016 Q1
11 quarters
|
|
158
Waters Corp
WAT
$43.6B
| $59.7M | 0.05% |
316,617
-3,900
| -1% | -$741K |
2013 Q2
22 quarters
|
|
159
DELISTED
Paramount Global Class B
PARA
| $59.5M | 0.05% |
1,361,549
-444,828
| -25% | -$23.6M |
2016 Q4
8 quarters
|
|
160
Capri Holdings
CPRI
$1.8B
| $59.3M | 0.05% |
1,563,800
+1,256,100
| +408% | +$63.2M |
2018 Q2
2 quarters
|
|
|
EPZM
161
DELISTED
Epizyme, Inc
EPZM
| $58.9M | 0.05% |
9,556,527
-112,400
| -1% | -$858K |
2013 Q2
22 quarters
|
|
162
Standard BioTools
LAB
$258M
| $57.5M | 0.05% |
6,671,043
+815,000
| +14% | +$6.35M |
2013 Q2
22 quarters
|
|
|
ARNA
163
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $57M | 0.05% |
1,464,000
+475,601
| +48% | +$18.7M |
2018 Q3
1 quarter
|
|
164
Restaurant Brands International
QSR
$25.8B
| $56.6M | 0.05% |
1,082,400
+48,000
| +5% | +$2.67M |
2017 Q4
4 quarters
|
|
165
Pentair
PNR
$8.53B
| $55.4M | 0.04% |
1,466,500
-850
| -0.1% | -$34.4K |
2013 Q2
22 quarters
|
|
166
Cerus
CERS
$455M
| $54.8M | 0.04% |
10,800,000
+500,000
| +5% | +$2.9M |
2015 Q1
15 quarters
|
|
167
Axcelis
ACLS
$3.55B
| $52.6M | 0.04% |
2,952,400
-900
| -0% | -$16K |
2014 Q1
19 quarters
|
|
168
Hilton Worldwide
HLT
$77.2B
| $50.3M | 0.04% |
700,965
-158,400
| -18% | -$11.4M |
2015 Q2
14 quarters
|
|
169
Travelers Companies
TRV
$80.1B
| $47.9M | 0.04% |
399,775
| – | – |
2016 Q2
10 quarters
|
|
170
T-Mobile US
TMUS
$168B
| $46.9M | 0.04% |
736,900
+21,200
| +3% | +$1.42M |
2017 Q1
7 quarters
|
|
171
Charter Communications
CHTR
$12.6B
| $46.5M | 0.04% |
163,300
| – | – |
2016 Q2
10 quarters
|
|
172
DELISTED
Southwestern Energy Company
SWN
| $46.5M | 0.04% |
13,627,825
+1,221,725
| +10% | +$6.01M |
2013 Q2
22 quarters
|
|
173
Charles River Laboratories
CRL
$14.6B
| $45.7M | 0.04% |
404,100
-17,000
| -4% | -$2.13M |
2013 Q2
22 quarters
|
|
174
Las Vegas Sands
LVS
$24.8B
| $44.6M | 0.04% |
857,300
+67,800
| +9% | +$3.68M |
2013 Q2
22 quarters
|
|
|
LGF.B
175
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $43M | 0.03% |
2,886,500
-43,700
| -1% | -$788K |
2016 Q4
8 quarters
|
|
Similar funds
Primecap Management's Q4 2018 Portfolio in Review
As of Q4 2018, Primecap Management held 304 positions worth $123B, down 17% from $148B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management's Q4 2018 filing shows 10 new, 88 increased, 149 reduced and 13 closed positions. Its largest new stake was Linde: 1,431,369 shares worth $223M. The largest sale was Eli Lilly, an estimated $468M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2018 buy was Linde: 1,431,369 shares worth $223M.
- Primecap Management added most to Bank of America in Q4 2018, an estimated $485M increase.
- Primecap Management's biggest Q4 2018 reduction was Eli Lilly, cutting an estimated $468M.
- Primecap Management fully exited Praxair Inc in Q4 2018, selling an estimated $231M.
- Primecap Management's ten largest holdings make up 30% of its $123B portfolio in Q4 2018.
- Primecap Management opened 10 new positions and closed 13 in Q4 2018.
- Primecap Management's portfolio value fell 17% quarter-over-quarter to $123B.
Based on Primecap Management's 13F filing for Q4 2018, filed 12 Feb 2019.